ResearcherFirst Hospital of China Medical UniversityNo recent work listed
Yunpeng Liu
Matched on ORCID iD 0000-0002-9645-7990; OpenAlex author ID A5013698513. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2018: 1 paper · 2019: none · 2020: 1 paper
Papers 2
- PD-L1 upregulation accompanied with epithelial-mesenchymal transition attenuates sensitivity to ATR inhibition in p53 mutant pancreatic cancer cells. Last author DOI 10.1007/s12032-020-01372-y↗
- MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12885-018-4526-z↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaofang Che · 2 shared papers, 2018–2020 · strength 0.18
- Paper PD-L1 upregulation accompanied with epithelial-mesenchymal transition attenuates sensitivity to ATR inhibition in p53 m… DOI 10.1007/s12032-020-01372-y↗
- Paper MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-018-4526-z↗
- Ce Li · 2 shared papers, 2018–2020 · strength 0.18
- Paper PD-L1 upregulation accompanied with epithelial-mesenchymal transition attenuates sensitivity to ATR inhibition in p53 m… DOI 10.1007/s12032-020-01372-y↗
- Paper MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-018-4526-z↗
- Na Song · 1 shared paper, 2020 · strength 0.11
- Wei Jing · 1 shared paper, 2020 · strength 0.11
- Xianghong Yang · 1 shared paper, 2018 · strength 0.07
- Xiujuan Qu · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.